Piper Jaffray Lowers PT on Baxter International to $65

Symbols: BAX
Share

Piper Jaffray has lowered the price target on Baxter International (NYSE: BAX) from $66 to $65 and maintains its Overweight rating.


 
 
< Previous
UPDATE: Credit Suisse Raises Target to $90 on Colgate-Palmolive
Next >
Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust